Edit search
Targeted prostate cancer screening in men with mutations in …
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer%3A preliminary analysis of the results of the IMPACT study.
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer%3A preliminary analysis of the results of the IMPACT study.
Article, Chapter
Authors: A.V. Mitra
Publication: BJU International, Volume:107, Issue:1, Page(s):28-39
Published: Wiley
ISSN: 1464-4096
  Full text availability for this item
Browse related articles
  Print copies at your library
  Request a copy of this item
Cite this item